FILE - Dr. Tedros Ghebreyesus, Director General of the WHO, speaks at the Reaching The Last Mile Forum on Nov. 19, 2019, at the Louvre in Abu Dhabi.(Jonathan Gibbons/Reaching the Last Mile Forum via AP Images)
The head of the World Health Organization says he will begin an independent evaluation of the U.N. health agency’s response to the coronavirus pandemic “at the earliest appropriate moment.”
WHO Director-General Tedros Adhanom Ghebreyesus made the pledge Monday after an independent oversight advisory body published its first interim report about the U.N. health agency’s response to COVID-19 from January to April.
The 11-page report raised questions such as whether WHO’s warning system for alerting the world to outbreaks is adequate, and suggested member states might need to “reassess” WHO’s role in providing travel advice to countries.
The advisory body’s review and recommendations appeared unlikely to appease the United States administration, which has been scathing in its criticism of WHO — in part over President Donald Trump’s allegation that it had criticized a U.S. travel ban that he ordered on people arriving from China, where the outbreak first appeared late last year.
Trump ordered a temporary suspension of funding for WHO from the United States — the health agency’s biggest single donor — pending a review of its early response. But the review panel, echoing comments from many countries, said such a review during the “heat of the response” could hurt WHO’s ability to respond to it.
The Supreme Court on Wednesday said it will hear an appeal that could upend hundreds of charges stemming from the Capitol riot, including against former President Donald Trump.
The Federal Reserve kept its key interest rate unchanged Wednesday for a third straight time, and its officials signaled that they expect to make three quarter-point cuts to their benchmark rate next year.
Hunter Biden on Wednesday defied a congressional subpoena to appear privately for a deposition before Republican investigators who have been digging into his business dealings, insisting outside the U.S. Capitol that he will only testify in public.
The Supreme Court agreed on Wednesday to take up a dispute over a medication used in the most common method of abortion in the United States, its first abortion case since it overturned Roe v. Wade last year.
